Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-06

Clinical Trial Update: Metformin for Preventing Frailty in High-risk Older Adults [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports results on using metformin to prevent frailty in high-risk older adults, with the study completed and results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Frailty | Phase 2 | Status: COMPLETED | Results posted: 2025-08-06